Skye Bioscience (SKYE) Short-Term Debt issuances (2022 - 2023)
Skye Bioscience (SKYE) posted quarterly Short-Term Debt issuances of -$236681.0 for Q4 2023, down 163.76% year-over-year from $371203.0 in Q4 2022, and down 448.26% quarter-over-quarter from $67961.0 in Q3 2023.
Skye Bioscience (SKYE) Short-Term Debt issuances (2022 - 2023) Analysis & Trends
Skye Bioscience (SKYE) has reported Short-Term Debt issuances for 2 consecutive years, with -$236681.0 the latest figure, recorded in Q4 2023.
- In Q4 2023, Short-Term Debt issuances fell 163.76% year-over-year to -$236681.0; the TTM figure through Sep 2024 stood at -$236681.0 (down 138.94% YoY), while the FY2022 annual figure was $616125.0, changed N/A from the prior year.
- Short-Term Debt issuances fell to -$236681.0 in Q4 2023 per SKYE's latest filing, from $67961.0 in the prior quarter.
- Across five years, Short-Term Debt issuances topped out at $371203.0 in Q4 2022 and bottomed at -$236681.0 in Q4 2023.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Short-Term Debt issuances (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 139.13 Bn | 131.28 Bn | 2.84 Bn | - |
| 2 | Regeneron Pharmaceuticals | 85.77 Bn | 77.77 Bn | 3.93 Bn | - |
| 3 | Argenx Se | 64.64 Bn | 59.46 Bn | 1.37 Bn | - |
| 4 | Moderna | 58.29 Bn | 53.16 Bn | 52.00 Mn | - |
| 5 | BeOne Medicines | 41.92 Bn | 36.82 Bn | 1.53 Bn | - |
| 6 | Alnylam Pharmaceuticals | 31.58 Bn | 28.28 Bn | 992.69 Mn | - |
| 7 | BioNTech SE | 28.12 Bn | 9.73 Bn | 668.28 Mn | - |
| 8 | Insmed | 27.39 Bn | 26.22 Bn | 358.27 Mn | - |
| 9 | Royalty Pharma | 27.27 Bn | 26.43 Bn | - | - |
| 10 | Skye Bioscience | 10.86 Mn | 10.86 Mn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2023 | -236,681.00 |
| Dec 31, 2023 | -236,681.00 |
| Sep 30, 2023 | 67,961.00 |
| Sep 30, 2023 | 67,961.00 |
| Jun 30, 2023 | 123,413.00 |
| Jun 30, 2023 | 123,413.00 |
| Mar 31, 2023 | 45,307.00 |
| Mar 31, 2023 | 45,307.00 |
| Dec 31, 2022 | 371,203.00 |
| Dec 31, 2022 | 371,203.00 |
| Sep 30, 2022 | 91,846.00 |
| Sep 30, 2022 | 91,846.00 |
| Jun 30, 2022 | 91,846.00 |
| Jun 30, 2022 | 91,846.00 |
| Mar 31, 2022 | 61,230.00 |
| Mar 31, 2022 | 61,230.00 |